| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.03 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |